Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

This study has been terminated.
(administrative reasons)
Information provided by:
InterMune Identifier:
First received: April 1, 2003
Last updated: October 30, 2007
Last verified: October 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2004
  Estimated Primary Completion Date: No date given